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Abstract 
Tetraclinis articulata (Cupressaceae), a traditional Moroccan herbal drug is used in oriental Morocco to treat diabetes and 
arterial hypertension. In another study we showed that the crude aqueous extract of T. articulata induces endothelium-
dependent relaxation of the isolated rat aorta. The aim of this work is to identify the active compounds that may explain this 
effect using the bioguided fractionation method. Twigs of T. articulata were extracted successively with different solvents 
and the obtained extracts were tested in phenylephrine-precontracted rat aortic rings. Ethyl acetate and methanolic Soxhlet 
extracts have shown a well vasorelaxant activity. Then active extracts of T. articulata were analysed by thin layer 
chromatography (TLC) and liquid chromatography with diode array detection and sometimes mass spectrometry (LC-
DAD/MS). The phytochemical analysis of the extracts has revealed the presence of a number of polyphenolic compounds 
known for their vasorelaxant effect such as amentoflavone, myricitrin and quercitrin. Their presence could explain the 
traditional use of T. articulata twigs in the treatment of hypertension in oriental Morocco. 
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2. Introduction 
Hypertension is a cardiovascular disease with the highest epidemiological impact in the world, and represents a major risk 
factor for other diseases such as endothelium and renal dysfunctions, diabetes, congestive heart failure, coronary artery 
diseases and stroke [1]. Therefore, many investigations were carried out in order to prevent this disease, by using various 
therapies, including the phytotherapy [2]. In Morocco, many medicinal plants are used in the cardiovascular system 
pharmacopoeia [2-5] which include Tetraclinis articulata (Cupressaceae). This species is endemic to northern Africa [6] 
and the largest populations are found in Morocco [7]. The plant is used in folk medicine as an emetic, antidiarrheal, against 
dizziness and fever, and to treat inflammation of the eyes [8]. In oriental Morocco, it is one of the commonly used plants to 
treat diabetes and arterial hypertension [2]. Many studies have focused especially on the essential oils composition of 
T.articulata. Bourkhiss and colleagues (2007) have identified 34 compounds by GC and GC / MS in the essential oil 
extracted from the leaves of Moroccan T. articulata. The main components are: bornyl acetate (30.74%), α-pinene 
(23.54%), camphor (17.27%) and limonene (23.31%) [7]. The branches of T. articulata contain bornyl acetate (30.5%), 
camphor (18.6%), borneol (10.2%), limonene (8.6%), terpinen-1-ol-4 (5.8%) and less than (0.1%) of thuyone. For the 
wood, it contains carvacrol (28%),  p-methoxythymol (22.1%), thymohydroquinone (16.1%), cedrol (7.2%), terpinen-4-1ol 
(5.4%), α-pinene (3.8%)  and α –cedrene (3.6%)  [9]. 
In another study (submitted) we showed that the crude aqueous extract of T.articulata twigs induces endothelium-
dependent relaxation of the isolated rat aorta. So, in this study, we attempted to demonstrate the vasorelaxant effect of 
Soxhlet extracts of T. articulata on rat isolated thoracic aorta and to identify the active compounds that may explain this 
effect using the bioguided fractionation method. 
3. Materials and methods  
1. Plant material  
Scally leaves (twigs) of T. articulata (Vahl) Master were collected from Tafoughalt in oriental Morocco in Mai 2010. A 
taxonomic identification was performed by Pr. B. Haloui from the Biology Department of Oujda Sciences Faculty 
(Morocco) where a voucher sample was deposited under the number ZL34. 
2. Animals 
Male and female Wistar rats weighing 250-300g were obtained from our local colonies. They were kept under conditions of 
constant temperature (22±2°C) with a standard 12-h light: 12-h dark cycle and free access to food and water. All animals 
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were cared for in compliance with the Guide for the Care and Use of Laboratory Animals, published by the US National 
Institutes of Health (NIH Publication 85-23, revised 1996; see http://grants.nih.gov/grants/olaw/olaw.htm).  
3. Standards and chemicals 
The following drugs: Phenylephrine (Phen), Carbachol (Cch), were obtained from Sigma chemical. All compounds and 
extractions were dissolved in distilled water except ethyl acetate extract which was dissolved in DMSO. 
Myricitrin, Quercitrin, Amentoflavone, Cupressuflavone, Catechin, Epicatechin, and Epigallocatechin were purchased from 
“Extrasynthese” (Lyon, France). 
HPLC grade acetonitrile and methanol were purchased from Merck (Germany). Water used for the HPLC analysis was 
obtained from a Millipore system (Milli-Q RG) (Merck Millipore, Germany). All other solvents were of analytical grade 
and were purchased from Merck (Germany).Reactive “R” is described in the European Pharmacopea [10]. 
4. Preparation of extracts  
a. The crude aqueous extract of T. articulata twigs 
The dried and pulverized twigs (50g) were extracted  by decoction with 1l of distilled water during 30 min. After filtration, 
the filtrate was dried under reduced pressure at 40°C. The yield of extraction is approximately 9% of the dried plant.  
b. Successive Soxhlet extracts 
Different extracts were prepared from 60g of pulverized twigs. The powder was seriatim extracted with hexane, 
dichloromethane, ethyl acetate, methanol in a Soxhlet apparatus, using 600 ml of each solvent. 
After filtration, the different solutions were dried under reduced pressure at 40°C and called Soxhlet extract in the 
manuscript. Each extract was prepared at different concentrations for the pharmacological testing. 
5. Chromatographic and MS conditions  
a. General Thin-layer chromatography conditions 
100 mg of each extract is dissolved in 10 ml of methanol. Each standard solution was prepared by dissolving 1mg of 
substance in 1ml of methanol. The solutions test and standards (10 µl) were spotted on silicagel 60 F 254 (Merck) as 5mm 
bands. Plates were developed over a path of 10 cm in a saturated chamber (60 min) at room temperature. 
b. TLC of glycosylated flavonoids  
The mobile phase used was:  ethyl acetate, formic acid, acetic acid glacial, water (100: 11: 11: 26). The plates were dried 
at 100-105 °C for 10 min and then sprayed  with a solution of diphenylboric acid aminoethyl ester R (DPBAE) (100 mg) 
and 500 mg  of macrogol 400 R in methanol (100 ml); allow to dry in air for about 30 min and finally examined in 
ultraviolet light at 365 nm. This reagent is described in the European pharmacopoeia [10]. 
c. TLC of aglycone flavonoids 
The mobile phase used was:  formic acid, acetone, dichloromethane (7: 20.5 : 70.5). The plates were dried at 100-105 °C 
for 10 min and then sprayed with the above reagent (DPBAE and macrogol). 
d. TLC of catechins and gallocatechins  
The upper phase of ethyl acetate-water-formic acid-acetic acid (70:20:3:2) was used as mobile phase. Following 
development, the plate was dried and sprayed with a 1% vanillin solution in methanol-hydrochloric acid (8:2). The colours 
of the bands were observed in the visible 5 min after spraying. 
e. HPLC conditions 
100 mL of methanol were added to 10 mg of each analysed extract. Each standard solution was prepared by dissolving 1 
mg of substance in 10 mL of methanol. Solutions were filtered through Chromafil® Pet -45/25 Macherey-Nagel (Germany) 
filter. Chromatographic analysis was performed using an Agilent 1100 HPLC coupled with a DAD (Diode-Array Detector). 
The column was a hypersil ODS (5 µm, 250 × 4.6 mm) and the analysis operated at 25 ºC. The mobile phase was 
composed of two solvents: Trifluoroacetic acid 0.05 % in water (A) and Acetonitrile (B). A linear gradient was  
programmed as follows: at 0 min100.% (A) and 0.0% (B), 1 min 97% A and 3.0% (B), 45 min 60% A and 40.0% (B), 55 
min 60% A and 40.0% (B), 56 min 40% A and 60.0% (B), and 66 min 40% A and 60.0% (B),67 min 100.% (A) and 0.0% 
(B), The flow rate was 1 ml/min and the injected volume was 2 µl. The peaks were recorded using UV absorbance at 280 
nm and 350 nm.  
Preparative HPLC (Varian) was performed on Lichrospher 100 RP 18 column Merck® (250 x 25 mm, 12 µm). 1 g of 
methanolic extract was dissolved in methanol (10 ml) and filtered through Acrodisc PSF GXF/GHP 0.45 nm filter and 
injected in PrepHPLC. The mobile phase consisted of TFA 0.05% (A) and acetonitrile (B), which was applied in the 
following gradient elution: 0 min 100% A; 1 min 97% A; 45 min 60% A; 55 min 60% A; 56 min 40% A and 66 min 40% 
A. Flow rate was 30 ml/min. Detection was performed at 350 nm and time of collect is 0.20 min. The isolated compounds 
(myricitrin; quercitrin; amentoflavone and cupressuflavone) were identified by comparison with standards and by LC/DAD 
and MS. 
f. Mass Spectra 
Mass spectra were set to negative ion mode. Experiments were performed with a 9.4 tesla Apex-Qe FTICR mass 
spectrometer (Bruker Daltonics, Billerica, MA).  
g. Polyphenols and tannins assays 
For the assay of tannins and polyphenols we followed the method described in the European pharmacopoeia [10]. 
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6. Preparation of aorta and experiment device  
Animals were anesthetised with sodium pentobarbital (50mg/kg of body weight, i.p.) and then the thoracic aorta was 
removed carefully in cold physiological salt solution (PSS). After the removal of adhering fatty and connective tissues, an 
aortic ring (about 2-3mm in length) was suspended between two stainless steel hooks in a 10 ml water-jacked bath 
containing PSS of the following composition (mM): NaCl 119, KCl 4.7, CaCl2 1.6, MgSO4 1.2, NaHCO3 25, glucose 11. 
The tissue bath solution with pH 7.4 was maintained at 37°C and gassed with 95% O2+5% CO2. The isometric contraction 
was recorder via a force-displacement transducer (EMKA Technologies, Paris, France) connected to a polygraph (Leybold-
Heraeus, Austria). A tension of 1g was initially applied to the ring which was equilibrated in the medium for 30min. Before 
each experiment, vasoconstriction was induced by 1µM of Phen in normal PSS and when the steady contraction was 
reached, 100µM Cch was added to induce endothelium-dependant relaxation. This step was necessary to verify the 
endothelium integrity. When the relaxation induced by Cch was less than 50%, the experiment was interrupted and another 
ring was mounted. Twenty min after the Phen/Cch step others experiments have been performed as follows. 
7. Effect of Soxhlet extracts of T. articulata on intact aorta  
In order to identify the main chemical components that justify the vasorelaxant property of T. articulata, aortic ring 
preparation with intact endothelium were exposed to cumulative increasing concentrations of different soxhlet extracts  
(103, 10-2, 10-1 and 1g/l) during 5min, once the maximum phenylephrine-induced contraction was established. 
8. Statistical analysis  
The results are expressed as the mean ± SEM; they were expressed as percentage of relaxation of Phen-Precontracted aorta 
(compared to a maximal contraction induced by Phen). Data obtained were analysed using unpaired Student’s t-test and a 
difference was considered statistically significant when p < 0.05. 
4. Results  
1. Vascular effect of T. articulata Soxhlet extracts  
The hexane and dichoromethane Soxhlet extracts do not show interesting activity. On the contrary, ethyl acetate and 
methanol extracts caused an important vasorelaxant effect that reaches 77 ±16% (n=6; p<0.05; 1g/l) and 56 ±5.6% 
(n=6; p<0.05; 10-1 g/l) respectively (Fig.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Typical tracing showing the effect of cumulative concentrations of successive Soxhlet extracts (10-3, 10-2, 10-1 
and 1 g/l) on intact aorta precontracted by Phen (1µM) (A: ethyl acetate extract; B: methanolic extract). 
2. Identification of Polyphenols (flavonoids and flavan-3-ols) 
A preliminary phytochemical screening of T. articulata crude aqueous and methanolic extracts was realized by TLC 
in comparison with reference standards. This analysis revealed the presence of two major glycosylated flavonoids 
(orange at 365 nm with diphenylboric acid aminoethyl ester  reagent) subsequently determined as quercitrin (Fig. 2.a) 
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and myricitrin (Fig.2.b) and two major aglycone flavonoids (yellow at 365 nm with precedent reagent) being 
cupressuflavone and amentoflavone ( Fig. 3A). The plates examined in the system used for flavan-3-ols, afforded red 
colours with vanillin/hydrochloric reagent: several compounds have same retention time as catechin, epicatechin, 
epigallocatechin standards and other red colored compounds indicating the presence of flavan-3-ols dimers and 
oligomers (Fig. 3B) [11]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: TLC of glycosylated flavonoids : A: TLC showing the presence of quercitrin in the aqueous, ethyl 
acetate and methanolic extracts (a: ethyl acetate extract, b: aqueous extract, c: Methanolic extract; Standards: d: 
quercitrin) ; B: TLC showing the presence of myricitrin in the methanolic extract (c); e: myricitrin (standard) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A: TLC of aglycone flavonoids showing the presence of amentoflavone in the ethyl acetate extract 
(a), f: amentoflavone (standard); B: TLC of flavan-3-ols showing the presence of catechin and epicatechin (a: ethyl 
acetate extract, b: aqueous extract, c: Methanolic extract; Standards: g: catechin and epicatechin) 
 
The HPLC DAD of different extracts (Fig5) confirms the presence of myricitrin and quercitrin and shows a third 
peak which could be afzelin (kaempferol-3-rhamnoside). In addition, the HPLC chromatogram of ethyl acetate 
extract showed at 350 nm two other main peaks corresponding to aglycone flavonoids (Fig 4, peaks 4 and 5). These 
have been isolated by preparative HPLC: both had the same molecular formula determined to be C30H18O10 by HR-
ESIMS analysis ([M - H]- at m/z 537.0828) (see annex). They were biflavones derived from apigenin, identified 
respectively as amentoflavone (3’,8’’ biapigenin) and cupressuflavone (8, 8’’ biapigenin) by comparison with 
standards (TLC, LC and UV spectra) (Fig.5). These peaks are also observed on the chromatographic profile of the 
methanolic and aqueous extract but in very weak concentration. 
Otherwise, the chromatographic profile of aqueous, ethyl acetate and methanolic extracts measured at 280 nm 
showed the presence of catechin which has the same Rt (about 18 min) and UV spectrum as the standard. Other peaks 
with similar UV spectra showed the presence of other flavan-3-ols (monomers and dimers). This has confirmed the 
A B 
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TLC analysis which showed a profile of proanthocyanidins. In addition the assay of tannins using the European 
Pharmacopoeia method showed that the twigs of T. articulata were rich in tannins (over 4%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: HPLC chromatogram of different extracts (detection at 350 nm) 
Aqueous extract (decoction) - Ethyl acetate extract (Soxhlet) - Methanol extract (Soxhlet) 
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4. Discussion  
T. articulata has been used as a medicinal plant for many diseases including arterial hypertension 
study we have shown that the aqueous extract of 
endothelium-dependent relaxation via the endothelial eNOS/cGMP pathway. The activation of K
channels contributes in part to this effect
In this work we show that ethyl acetate and metanolic soxhlet extracts of 
isolated rat aorta precontracted with Phen (1µM).
Vasorelaxation effect of these extracts
biological and pharmacological activities including vasorelaxant effect.
Indeed, photochemical analysis of these extracts has clearly revealed the existence of a number of polyphenolic 
compounds (flavonols, flavones, flavan
In the aqueous and methanolic extracts, two principal flavonoids are found: myricitrin and quercitrin. 
Myricitrin, a flavonol known for its several pharmacologic effects [14, 15], is used as an important supplement in 
functional foods, cosmetics and medicines because of its high antioxidative activity [16, 17]; it is known to also 
possess antinociceptive [18], anti-inflammatory [19] and antiallodynic activity [20]. Others studies have indicate that 
myricitrin treatment prevents the development of atherosclerosis [21] and have suggested that this component inhibits 
reactive oxygen species-induced vascular endothelial cell apoptosis by regulation of antioxidant enzyme activity and 
the expression of apoptosis-related genes 
prevention and treatment of cardiovascular disease. 
In the aqueous and methanolic extracts of 
studies have described that quercetin as an efficient antihypertensive agent in several experimental models of 
hypertension in rats when is administered at the dose of 10 mg/kg of body weight. This antihypertensive effect has 
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been related to the protective antioxidant effects of quercetin which lead to improved bioavailability of endothelial-
derived NO [22-24].   
Furthermore, we have shown in this work that T. articulata is rich in flavan-3-ols (monomers, oligomers and 
tannins); these compounds are known for their vasorelaxant endothelium-dependent effect [25, 26]. Indeed, the 
presence of flavan-3-ols in aqueous methanol extracts could also play an important role in the vascular activity as 
described in the literature. So, various catechins induce a vasorelaxation that has been studied in different models [27, 
28]. For example, the phytochemical analysis of Arbutus unedo (plant used to treat diabetes and arterial hypertension 
in oriental Morocco) shows the presence of condensed tannins and catechin gallate which are responsible for the 
vasorelaxant effect of the plant via the NO/cGMP pathway [26 , 29]. Other studies show that (+) epicatechin and (+) 
catechin produce an endothelium-independent vasorelaxation [30]. They may produce relaxation through 
mechanisms such as inhibition of muscle cells protein kinase C, inhibition of cyclic nucleotide phophodiesterases 
[31] or decreased Ca2+ uptake in smooth muscle cells, as previously reported by the group of Duarte in the same 
preparation [31, 32]. 
Finally, in our ethyl acetate extract we founded amentoflavone (biflavonoids) which is known to possess many 
pharmacological properties including hypotensive [33; 34]. Indeed, amentoflavone induces a vasorelaxation 
endothelium-dependant via nitric oxide-cGMP signalling, with possible involvement of non-specific K+ and Ca2+ 
channels [33]. 
Conclusion 
The phytochemical analysis of the extracts has revealed the presence of a number of polyphenolic compounds known for 
their vasorelaxant effect such as amentoflavone, myricitrin and quercitrin. Their presence could explain the traditional use 
of T. articulata twigs in the treatment of hypertension in oriental Morocco. 
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Annex 
Mass spectra of myricitrin ([M - H]- at m/z 463.08) (peak 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mass spectra of cupressuflavone ([M - H]- at m/z 537.0828) (peak 4) 
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